SMAD4 and ovarian mucinous neoplasm: To the best of our knowledge, mutations within FGFR2, ERBB2 (missense/activating), STK11, GNA11, SRC, CTNNB1, and SMAD4 have not been previously reported in mucinous ovarian tumors.